Chemokine immunobiology in HIV-1 pathogenesis

Journal of Leukocyte Biology

Volumn 65, Issue 5, 1999, Pages 552-565

  Lee, Benhur ^a,b   Montaner, Luis J ^a  

^a WISTAR INSTITUTE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemokine receptors; Cytokines

Indexed keywords

CHEMOKINE;

ARTICLE; EFFECTOR CELL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOBIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

EID: 0032909805     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.65.5.552     Document Type: Article

References (193)

1. Berger, E. A. (1998) Introduction: HIV co-receptors solve old questions and raise many new ones. Semin. Immunol. 10, 165-168.
2. Cohen, O. J., Kinter, A., Fauci, A. S. (1997) Host factors in the pathogenesis of HIV disease. Immunol. Rev. 159, 31-48.
3. Husman, A. M. D., Schuitemaker, H. (1998) Chemokine receptors and the clinical course of HIV-1 infection. Trends Microbiol. 6, 457-470.
4. + T-lymphocyte-derived chemokines and other HIV-suppressive factors: mini-review. J. Chemother. 10, 146-149.
5. Garzino-Demo, A., Devico, A. L., Gallo, R. C. (1998) Chemokine receptors and chemokines in HIV infection. J. Clin. Immunol. 18, 243-255.
6. Virelizier, J. L. (1998) Alternative, cytokine-mediated host defense mechanisms against HIV infection: the concept of self-limitation of HIV replication. AIDS 12, S141-S146.
7. Ward, S. G., Westwick, J. (1998) Chemokines: understanding their role in T-lymphocyte biology. Biochem. J. 333, 457-470.
8. Ward, S. G., Bacon, K., Westwick, J. (1998) Chemokines and T lymphocytes: More than just an attraction. Immunity 9, 1-11.
9. Moore, J. P., Trkola, A., Dragic, T. (1997) Coreceptors for HIV-1 entry. Curr. Op. Immunol. 9, 551-562.
10. Doms, R. W., Peiper, S. C. (1997) Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. Virol. 235, 179-190.
11. Tachihana, K., Hirota, S., Iizasa, H., Yoshida, H., Kawabata, K., Kataoka, Y., Kitamura, Y., Matsushima, K., Yoshida, N., Nishikawa, S., Kishimoto, T., Nagasawa, T. (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393, 591-594.
12. Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I., Littman, D. R. (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599.
13. Rollins, B. J. (1997) Chemokines. Blood 90, 909-928.
14. Lee, B., Doranz, B. J., Ratajczak, M. Z., Doms, R. W. (1998) An intricate web: chemokine receptors, HIV-1 and hematopoiesis. Stem Cells 16, 79-88.
15. Wells, T. N. C., Proudfoot, A. E. I., Powers, C. A., Lusti-Narasimhan, M., Alouani, S., Hoogewerf, A. J., Peitsch, M. C. (1996) The molecular basis of the chemokine/chemokine receptor interaction - scope for design of chemokien antagonists. Methods 10, 126-134.
16. Mackay, C. R. (1997) What chemokine is that? Curr. Biol. 7, R384-R386.
17. Ahuja, S. K., Murphy, P. M. (1993) Molecular piracy of mammalian interleukin-8 receptor type B by Herpesvirus saimiri. J. Biol. Chem. 268, 20691-20694.
18. Moore, P. S., Chang, Y. (1998) Antiviral activity of tumor-suppressive pathways: clues from molecular piracy hy KSHV. Trends Genet. 14, 144-150.
19. Murphy, P. M. (1994) Molecular piracy of chemokine receptors by herpesviruses. Infect. Agents Dis. 3, 137-154.
20. Doms, R. W., Edinger, A. L., Moore, J. P. (1999) Coreceptor use by primate lentiviruses. In Human Retroviruses and AIDS 1998, Volume III (B. Korber, B. Foley, T. Leitner, G. Myers, B. Hahn, F. McCutchan, J. Mellors, and C. Kuiken, eds.), Los Alamos, NM: Los Alamos National Laboratory, Theoretical Biology and Biophysics, 1-12.
21. Rucker, J., Edinger, A. L., Sharron, M., Samson, M., Lee. B., Berson, J. F., Yi, Y., Collman, R. G., Doranz, B. J., Parmentier, M., Doms, R. W. (1997) Utilization of chemokine receptors, orphan receptors, and herpesvirus encoded receptors by diverse human and simian immunodeficiency viruses. J. Virol. 71, 8999-9007.
22. Doms, R. W., Moore, J. P. (1998) HIV coreceptor use: A molecular window into viral tropism. In Human Retroviruses and AIDS 1997, Volume III (B. Korber, B. Foley, T. Leitner, G. Myers, B. Hahn, F. McCutchan, J. Mellors, and C. Kuiken, eds.), Los Alamos, NM: Los Alamos National Laboratory, Theoretical Biology and Biophysics, 1-12.
23. Bieniasz, P. D., Cullen, B. R. (1998) Chemokine receptor and human immunodeficiency virus infection. Frontiers Biosci. 3, 44-58.
24. Gottlieb, M. S., Schroff, R., Schanker, H. M., Weisman, J. D., Fan, P. T., Wolf, R. A., Saxon, A. (1982) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. Evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med. 305, 1425-1431.
25. Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., Weiss, R. A. (1984) The CD4 (T4) antigen is an essential component of the receptor of the AIDS retrovirus. Nature 312, 763-767.
26. Klatzman, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T, Gluckman, J. C., Montagnier, L. (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768.
27. Broder, C. C., Dimitrov, D. S., Blumenthal, R., Berger, E. A. (1993) The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virol. 193, 483-491.
28. Dragic, T., Charneau, P., Clavel, F., Alizon, M. (1992) Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J. Virol. 66, 4794-4802.
29. Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., Berger, E. A. (1996) CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958.
30. Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., Gerard, N., Gerard, C., Sodroski, J. (1996) The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148.
31. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R., Landau, N. R. (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
32. Doranz, B. J., Rucker, J., Yi, Y., Smyth, R. J., Samson, M., Peiper, S. C., Parmentier, M., Collman, R. G., Doms, R. W. (1996) A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158.
33. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673.
34. Feng, Y., Broder, C. C., Kennedy. P. E., Berger, E. A. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane domain, G-protein coupled receptor. Science 272, 872-877.
35. Zhang, L., Carruthers, C. D., He, T., Huang, Y., Cao, Y., Wang, G., Hahn, B., Ho, D. D. (1997) HIV type I subtypes, coreceptor usage, and CCR5 polymorphism. AIDS Research Human Retroviruses 13, 1357-1366.
36. Zhang, L., He, T., Huang, Y., Chen, Z., Guo, Y., Wu, S., Kunstman, K. J., Brown, R. C., Phair, J. P., Neumann, A. U., Ho, D. D., Wolinsky, S. M. (1998) Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type I. J. Virol. 72, 9307-9312.
37. Zhang, Y. J., Dragic, T., Cao, Y., Kostrikis, L., Kwon, D. S., Littman, D. R., Kewal Ramani, V. N., Moore, J. P. (1998) Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type I is rare in vitro. J. Virol. 72, 9337-9344.
38. 4 T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67, 1772-1777.
39. Åsjö, B., Morfeldt, M. L., Albert, J., Biberfeld, G., Karlsson, A., Lidman, K., Fenyo, E. M. (1986) Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 2, 660#662.
40. Connor, R. I., Sheridan, K. E., Ceradini, D., Choe, S., Landau, N. R. (1997) Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J. Exp. Med. 185, 621-628.
41. Simmons, G., Wilkinson, D., Reeves, J. D., Dittman, M. T., Beddows, S., Weber, J., Carnegis, G., Gesselberger, U., Gray, P. W., Weiss, R. A., Clapham, P. R. (1996) Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70, 8355-8360.
42. Schuitemaker, H., Koot, M., Koostra, N. A., Dercksen, M. W., Goede, R. E. Y. D., Steenwijk, R. P. V., Lange, J. M. A., Schattenkerk, J. K. M. E., Miedema, F., Tersmette, M. (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell tropic populations. J. Virol. 66, 1354-1360.
43. Berger, E. A., Doms, R. W., Fenyo, E.-M., Korber, B. T. M., Littman, D. R., Moore, J. P., Sattentau, Q. J., Schuitemaker, H., J. Sodroski, Weiss, R. A. (1998) A new classification for HIV-1. Nature 391, 240.
44. Samson, M., Labbe, O., Mollereau, C., Vassart, G., Parmentier, M. (1996) Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35, 3362-3367.
45. Bleul, C. C., Farazan, M., Choe, H., Parolin, C., Clark-Lewis, I., Sodroski, J., Springer, T. A. (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/Fusin and blocks HIV-1 entry. Nature 382, 829-833.
46. Oberlin, E., Amara, A., Bachelerie, F., Bessia, C., Virelizier, J.-L., Arenzana-Seisdedos, F., Schwartz, O., Heard, J.-M., Clark-Lewis, I., Legler, D. F., Loetscher, M., Baggiolini, M., Moser, B. (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell line-adapted HIV-1. Nature 382, 833-835.
47. Gong, W., Howard, O., Turpin, J., Grimm, M., Ueda, H., Gray, P., Raport, C., Oppenheim, J., Wang, J. (1998) Monocyte chemotactic protein-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 entry/replication. J. Biol. Chem. 273, 4289-4292.
48. Ruffing, N., Sullivan, N., Sharmeen, L., Sodroski, J., Wu, L. (1998) CCR5 has an expanded ligand-binding repertoire and is the priamry receptr used by MCP-2 on activated T cells. Cell. Immuonol. 189, 160-168.
49. Schmidtmayerova, H., Nottet, H. S. L., Nuovo, G., Raabe, T., Flanagan, C. R., Dubrovsky, L., Gendelman, H. E., Cerami, A., Bukrinsky, M., Sherry, B. (1996) Human immunodeficiency virus type I infection alters chemokine beta peptide expression in human moncytes: Implications for recruitment oof leukocytes into brain and lymph nodes. Proc. Natl. Acad. Sci. USA 93, 700-704.
50. Sasseville, V. G., Smith, M. M., Mackay, C. R., Pauley, D. R., Mansfield, K. G., Ringler, D. J., Lackner, A. A. (1996) Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am. J. Pathol. 149, 1459-1467.
51. + T cells. Science 270, 1811-1815.
52. Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., Landau, N. R. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86, 367-377.
53. Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapoumèroulie, C., Cogniaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G., Parmentier, M. (1996) Resistance to HIV-1 infection of Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 382, 722-725.
54. Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., Donfield, S., Vlahov, D., Kaslow, R., Saah, A., Rinaldo, C., Detels, R., Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, O'Brien, S. J. (1996) Genetic resistance of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273, 1856-1862.
55. Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., Kunstman, K., Erickson, D., Dragon, E., Landau, N. R., Phair, J., Ho, D. D., Koup, R. A. (1996) The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med. 2, 1240-1243.
56. Zimmerman, P. A., Bucklerwhite, A., Alkhatib, G., Spalding, T., Kubofcik, J., Combadiere, C. (1997) Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5-studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol. Med. 3, 23-26.
57. McNicholl, J. M., Smith, D. K., Qari, S. H., Hodge, T. (1997) Host genes and HIV: The role of the chemokine receptor gene CCR5 and its allele (D32CCR5). Emerg. Infect. Dis. 3, 261-271.
58. Samson, M., LaRosa, G., Libert, F., Paindavoine, P., Detheux, M., Vassart, G., Parmentier, M. (1997) The second extracellular loop of CCR5 is the major determinant of ligand specificity. J. Biol. Chem. 272, 24934-24941.
59. Wu, L., LaRosa, G., Kassam, N., Gordon, C. J., Heath, H., Ruffing, N., Chen, H., Humblias, J., Samson, M., Parmentier, M., Moore, J. P., Mackay, C. R. (1997) Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J. Exp. Med. 186, 1373-1381.
60. Atchison, R. E., Gosling, J., Monteclaro, F. S., Franci, C., Digilio, L., Charo, I. F., Goldsmith, M. (1996) Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274, 1924-1926.
61. Bieniasz, P. D., Fridell, R. A., Aramori, I., Ferguson, S. S. G., Caron, M. G., Cullen, B. R. (1997) HIV-1 induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 coreceptor. EMBO J. 16, 2599-2609.
62. Doranz, B. J., Lu, Z., Rucker, J., Zhang, T., Sharron, M., Cen, Y., Wang, Z., Guo, H., Du, J., Accavitti, M. A., Doms, R. W., Peiper, S. C. (1997) Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J. Virol. 71, 6305-6314.
63. Lu, Z., Berson, J. F., Chen, Y., Turner, J. D., Zhang, T., Sharron, M., Jenks, M. H., Wang, Z., Kim, J., Rucker, J., Hoxie, J. A., Peiper, S. C., Doms, R. W. (1997) Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc. Natl. Acad. Sci. USA 94, 6426-6431.
64. Rucker, J., Samson, M., Doranz, B. J., Libert, F., Berson, J., Yi, Y., Collman, R. G., Vassart, G., Broder, C. C., Doms, R. W., Parmentier, M. (1996) Regions in β-chemokine receptors CKR-5 and CKR-2b that determine HIV-1 cofactor specificity. Cell 87, 437-446.
65. Ross, T. M., Bieniasz, P. D., Cullen, B. R. (1997) Multiple residues contribute to the inability of murine CCR5 to function as a coreceptor for macrophage-tropic HIV-1 isolates. J. Virol. 1918-1924.
66. Lee, B., Sharron, M., Blainpai, C., Doranz, B. J., Vakili, J., Setoh, P., Tsang, M., Parmentier, M., Chang, C. N., Doms, R. W. (1999) Epitope mapping of CCR5 reveals multiple conformational states and distinct domains for chemokine and coreceptor function. J. Biol. Chem. in press.
67. Amara, A., Gall, S., Schwartz, O., Salamero, J., Montes, M., Loetscher, P., Baggiolini, M., Virelizier, J., Arenzana-Seisdedos, F. (1997) HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186, 139-46.
68. Signoret, N., Oldridge, J., Pelchen-Matthews, A., Klasse, P., Tran, T., Brass, L., Rosenkilde, M., Schwartz, T., Holmes, W., Dallas, W., Luther, M., Wells, T., Hoxie, J., Marsh, M. (1997) Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J. Cell Biol. 139, 651-664.
69. Trkola, A., Paxton, W. A., Monard, S. P., Hoxie, J. A., Siani, M. A., Thompson, D. A., Wu, L., Mackay, C. R., Horuk, R., Moore, J. P. (1998) Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines. J. Virol. 72, 396-404.
70. Doranz, B. J., Orsini, M. J., Turner, J. D., Hoffman, T. D., Berson, J. F., Lu, Z.-H., Hoxie, J. A., Peiper, S. C., Brass, L. F., Doms, R. W. (1999) Separation of SDF-1 binding, SDF-1 activation, and HIV-1 coreceptor utilization of CXCR4. J. Virol. in press.
71. Alkhatib, G., Ahuja, S. S., Light, D., Mummidi, S., Berger, E. A., Ahuja, S. K. (1997) CC chemokine receptor 5-mediated signaling and HIV-1 co-receptor activity share common structural determinants. J. Biol. Chem. 272, 19771-19776.
72. Farzan, M., Choe, H., Martin, K. A., Sun, Y., Sidelko, M., Mackay, C. R., Gerard, N. P., Sodroski, J., Gerard, C. (1997) HIV-1 entry and macrophage inflammatory protein 1β-mediated signaling are independent functions of the chemokine receptor CCR5. J. Biol. Chem. 272, 6854-6857.
73. Gosling, J., Monteclaro, F. S., Atchison, R. E., Arai, H., Tsou, C., Goldsmith, M. A., Charo, I. F. (1997) Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and singnal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94, 5061-5066.
74. Davis, C. B., Dikic, I., Unutmaz, D., Hill, C. M., Arthos, J., Siani, M. A., Thompson, D. A., Schlessinger, J., Littman, D. R. (1997) Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 186, 1793-1798.
75. Weissman, D., Rabin, R. L., Arthos, J., Rubbert, A., Dybul, M., Swofford, R., Venkatesan, S., Farber, J. M., Fauci, A. S. (1997) Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor. Nature 389, 981-985.
76. Wagner, L., Yang, O. O., Garcia-Zepeda, E. A., Ge, Y., Kalams, S., Walker, B. D., Pasternack, M. S., Luster, A. D. (1998) β-Chemokines are released from HIV-1 specific cytolytic T-cell granules complexed to proteoglycans. Nature 391, 908-911.
77. 2+ signalling. J. Exp. Med. 188, 1917-1927.
78. Amzazi, S., Ylisastigui, L., Bakri, Y., Rabehi, L., Gattegno, L., Parmentier, M., Gluckman, J. C., Benjouad, A. (1998) The inhibitory effect of RANTES on the infection of primary macrophages by R5 human immunodeficiency virus type-I depends on the macrophage activation state. Virology 252, 96-105.
79. Gordon, C. J., Muesing, M. A., Proudfoot, A. E. I., Power, C. A., Moore, J. P., Trkola, A. (1999) Enhancement of human immunodeficiency virus type I infection by the CC chemokine RANTES is independent the mechanism of virus-cell fusion. J. Virol. 73, 684-694.
80. Hadida, F., Vieillard, V., Autran, B., Clark-Lewis, I., Baggiolini, M., Debre, P. (1998) HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. J. Exp. Med. 188, 609-614.
81. Benyoucef, S., Hober, D., De Groote, D., Bocket, L, De La Tribonniere, X., Mouton, Y., Wattre, P. (1998) RANTES production in HIV-1 antigen-stimulated whole blood culture: relationship with type 1 immune response and plasma viral load in individuals infected with HIV-1. Scand. J. Immunol. 48, 212-216.
82. Schrum, S., Probst, P., Fleischer, B., Zipfel, P. (1996) Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta and RANTES is associated with a type-1 immune response. J. Immunol. 157, 3598-3604.
83. Siveke, J. T., Hamann, A. (1998) T helper 1 and T helper 2 cells respond differentially to chemokines. J. Immunol. 160, 550-554.
84. Loetscher, P., Uguccioni, M., Bordoli, L., Baggiolini, M., Moser, B., Chizzolini, C., Dayer, J. (1998) CCR5 is characteristic of Th1 lymphocytes. Nature 391, 344-345.
85. + T cells: Role of signal transduction. Proc. Natl. Acad. Sci. USA 95, 11880-11885.
86. Lee, B., Doranz, B. J., Rana. S., Yi, Y., Mellado, M., Frade, J. M. R., Martinez, A., C., O'Brien, S. J., Dean, M., Collman, R. G., Doms, R. W. (1998) Influence of the CCR2-V64I polymorphism on HIV-1 coreceptor activity and chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J. Virol. 72, 7450-7458.
87. Frade, J. M. R., Liorente, M., Mellado, M., Alcami, J., Guitierrez-Ramos, J. C., Zaballos, A., Real, G. D., Martinez, A. C. (1997) The amino-terminal domain of CCR2 chemokine receptor acts as coreceptor for HIV-1 infection. J. Clin. Invest. 100, 497-502.
88. Schols, D., Struyf, S., VanDamme, J., Este, J. A., Henson, G., DeClercq, E. (1997) Inhibition of T-tropic HIV strains by selective antogonization of the chemokine receptor CXCR4. J. Exp. Med. 186, 1383-1388.
89. Frade, J. M. R., Mellado, M., Real, G. D., Guiterrez-Ramos, J. C., Lind, P., Martinez, A. C. (1997) Characterization of the CCr2 chemokine receptor: Functional CCR2 receptor expression in B cells. J. Immunol. 159, 5576-5584.
90. Ayehunie, S., Garcia-Zepeda, E. A., Hoxie, J. A., Horuk, R., Kupper, T. S., Luster, A. D., Ruprecht, R. M. (1997) Human immunodeficeincy virus type-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors. Blood 90, 1379-1386.
91. Scarlatti, G., Tresdoldi, E., Bjornal, A., Fredriksson, R., Colognesi, C., Deng, H. K., Malnati, M. S., Plebani, A., Siccardi, A. G., Littman, D. R., Fenyo, E. M., Lusso, P. (1997) In vivo evolution of HIV-1 coreceptor usage and sensitivity to chemokine-mediated suppression. Nature Med. 3, 1259-1265.
92. Pal, R., Garzino-Demo, A., Markham, P. D., Burns, J., Brown, M., Gallo, R. C., Devico, A. L. (1997) Inhibition of HIV-1 infection by the β-chemokine MDC. Science 278, 695-698.
93. Imai, T., Chantry, D., Raport, C. J., Wood, C. L., Nishimura, M., Godiska, R., Yoshie, O., Gray, P. W. (1998) Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J. Biol. Chem. 273, 1764-1768.
94. Lee, B., Rucker, J., Doms, R. W., Tsang, M., HU, X., Dietz, M., Bailer, R., Montaner, L. J., Gerard, C., Sullivan, N., Sodroski, J., Stantchev, T. S., Broder, C. C. (1998) β-Chemokine MDC and HIV-1 infection. Science 281, 487.
95. Arenzana-Seisdedos, F., Amara, A., Thomas, D., Virelizier, J. L., Baleux, F., Clark-Lewis, I., Legler, D. F., Moser, B., Baggiolini, M. (1998) β-Chemokine MDC and HIV-1 infection. Science 281, 487a.
96. Struyf, S., Proost, P., Sozzani, S., Mantovani, A., Wuyts, A., Clercq, E. D., Schols. D., Damme, J. V. (1998) Enhanced anti-HIV-1 activity and altered chemotactic potency of NH2-terminally processed macrophage-derived chemokine (MDC) imply an additional MDC receptor. J. Immunol. 161, 2672-2675.
97. Oravecz, T., Pall, M., Wang, J., Rodriguez, G., Ditto, M., Norcross, M. A. (1997) Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans. J. Immuonol. 159, 4587-4592.
98. Kledal, T. N., Rosenkilde, M. M., Coulin, F., Simmons, G., Johnsen, A. H., Alouani, S., Ower, C. A., Luttichau, H. R., Gerstoft, J., Clapham, P. R., Clark-Lewis, L, Wells, T. N. C., Schwartz, T. W. (1997) A broad spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277, 1656-1659.
99. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N., Kikutani, H., Kishimoto, T. (1996) Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382, 635-638.
100. Mackewicz, C. E., Barker, E., Greco, G., Reyes-Teran, G., Levy, J. A. (1997) Do beta-chemokines have clinical relevance in HIV infection? J. Clin. Invest. 100, 921-930.
101. +, T-cell clones correlates with the clinical state of human immunodeficiency virus type I (HIV-1)-infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. J. Virol. 72, 876-881.
102. Zanussi, S., Andrea, M. D., Simonelli, C., Tirelli, V., Depaoli, P. (1996) Serum levels of RANTES and MIP-1α in HIV-1-positive long-term survivors and progressor patients. AIDS 10, 1431-1432.
103. Clerici, M., Balotta, C., Trabattuni, D., Papagno, L., Ruzzante, S., Rusconi, S., Fusi, M. L., Colombo, M. C., Galli, M. (1996) Chemokine production in HIV-1 seropositive long-term asympotomatic individuals. AIDS 10, 1432-1433.
104. Scala, E., D'offizi, G., Rooso, R., Turriziani, O., Ferrara, R., Mazzone, A. M., Antonelli, G., Aiuti, F., Paganelli, R. (1997) C-C chemokines, IL-16 and soluble anti-viral factor activity are increased in cloned T cells from subjects with long-term non-progressive HIV-1 infection. J. Immunol. 158, 4485-4492.
105. Margolis, L. B., Glushakova, S., Grivel, J. C., Murphy, P. M. (1998) Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines. J. Clin. Invest. 101, 1876-1880.
106. Zagury, D., Lachgar, A., Chams, V., Fall, L. S., Bernard, J., Zagury, J. F., Bizzini, B., Gringeri, A., Santagostino, E., Rappaport, J., Feldman, M., O'Brien, S. J., Burny, A., Gallo, R. C. (1998) C-C chemokine, pivotal in procteclion aginst HIV type I infection. Proc. Natl. Acad. Sci. USA 95, 3861-3867.
107. Power, C. A., Clemetson, J. M., Clemetson, K. J., Wells, T. N. (1995) Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine 7, 479-482.
108. Klinger, M. H., Wilhelm, D., Blubel, S., Sticherling, M., Schroder, J. M., Kuchnel, W. (1995) Immunocytochemical localization of the chemokines RANTES and MIP-1α within human platelets and their release during storage. Int. Arch. Allergy Immunol. 107, 541-546.
109. Blubel, S., Wilhelm, D., Entelmann, M., Kirchner, H., Kluter, H. (1996) Chemokines in stored platelet concentrates. Transfusion 36, 445-449.
110. + T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1beta. J. Immunol. 153, 4899-4906.
111. Tanaka, Y., Adams, D. H., Hubscher, S., Hirano, H., Siebenlist, U., Shaw, S. (1993) T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1beta. Nature 361, 79-82.
112. Witt, D. P., Lander, A. D. (1994) Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol. 4, 394-400.
113. 4 lymphocytes from exposed-uninfected individuals: association with low-expression of CCR5 and high productionof beta-chemokines. Virol. 244, 66-73.
114. Ullum, H., Cozzi, A., Vctor, J., Aladdin, A., Phillips, A. N., Gerstoft, J., Skinhej, P., Pedersen, B. K. (1998) Production of β-chemokines in human immunodeficiency infection: Evidence that high levels of macrophage inflammatory protein-1 beta are associated with a decreased risk of HIV disease progression. J. Infect. Dis. 133, 331-336.
115. Lehner, T., Wang, Y., Cranage. M., Bergmeier, L. A., Mitchell, E., Tao, L., Hall, G., Dennis, M., Cook, N., Brookes, R., Klavinski, L., Jones, I., Doyle, C., Ward, R. (1998) Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine macaques. Nature Med. 2, 767-775.
116. Heeney, J., Teeuwsen, V., Van Gils, M., Boogers, W., De Giuli Morghen, C., Radaelli, A., Barnett, S., Morein, B., Akerblom, L., Wang, Y., Lehner, T., Davis, D. (1998) B-Cemokines and neutralizing antibody titers correlate with sterilizing immunity generated in HIV-1 vaccinated macaques. Proc. Natl. Acad. Sci. USA 95, 10803-10808.
117. + T cells from exposed uninfected individuals expressing the wild-type CCR5-allele. J. Exp. Med. 186, 455-460.
118. Winkler, C., Modi, W., Smith, M. W., Nelson, G. W., Wu, X., Carrington, M., Dean, M., Honjo, T., Tashiro, K., Yabe, D., Buchbinder, S., Vittinghoff, E., Goedert, J. J., O'Brien, T. R., Jacobson, L. P., Detels, R., Donfield, S., Willoughby, A., Gomperts, E., Vlahov, D., Phair, J., study, A., HGDS, MACS, MHCS, SFCC, O'Brien, S. J. (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. Science 279, 389-393.
119. Ostrowski, M., Justements, S., Catanzaro, A., Hallahan, C., Ehler, L., Mizell, S., Kumar, P., Mican, J., Chun, T., Fauci, A. (1998) Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. J. Immunol. 161, 3195-3201.
120. Martin, M. P., Dean, M., Smith, M. W., Winkler, C., Gerrard, B., Michael, N., Lee, B., Doms, R. W., Margolick, J., Buchbinder, S., Goedert, J. J., O'Brien, T. R., Hilgartner, M. W., Vlahov, D., O'Brien, S. J., Carrington, M. (1998) Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 282, 1907-1911.
121. McDermott, D. H., Zimmerman, P. A., Guignard, F., Kleeberger, C. A., Leitman, S. F., Murphy, P. M. (1998) CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 352, 866-870.
122. + T-cell-mediated suppression of viral replication. Virology 244, 467-472.
123. + T cells. Proc. Natl. Acad. Sci. USA 95, 12556-12561.
124. + T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 395, 189-194.
125. Verani, A., Scarlatti, G., Comar, M., Tresoldi, E., Polo, S., Giacca, M., Lusso, P., Siccardi, A., Vercelli, D. (1997) C-C chemokines released by lipopolysaccharide (LPS) -stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J. Exp. Med. 185, 805-816.
126. Kornbluth, R., Oh, P., Munis, J., Cleveland, P., Richman, D. (1989) Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169, 1137-1151.
127. Moriuchi, H., Moriuchi, M., Fauci, A. (1997) Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. J. Immunol. 158, 3483-3491.
128. Marfaing-Koka, A., Maravic, M., Humbert, M., Galanaud, P., Emilie, D. (1996) Contrasting effects of IL-4, IL-10 and corticosteroids on RANTES production by human monocytes. Int. Immunol. 8, 1587-1594.
129. Wang, J., Roderiquez, G., Oravecz, T., Norcross, M. (1998) Cytokine regulaton of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J. Virol. 72, 7642-7647.
130. Lee, B., Bailer, R. T. Doms, R. W., Montaner, L. J. (1998) IL-13 complements with TNF-α to inhibit dual-tropic HIV infection of primary macrophages by reducing surface expression of CD4, CCR5, CXCR4 and post-fusion viral transcription. Blood, in press.
131. Wahl, S., Greenwell-Wild, T., Peng, G., Hale-Donze, H., Doherty, T., Mizel, D., Orenstein, J. (1998) Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression. Proc. Natl. Acad. Sci. USA 95, 12574-12579.
132. Kutza, J., Hayes, M., Clouse, K. (1998) Interleukin-2 inhibits HIV-1 replication in human macrophages by modulating expression of CD4 and CC-chemokine receptor-5. AIDS 12, 59-64.
133. Zella, D., Barabitskaja, O., Burns, J., Romerio, F., Dunn, D., Revello, M., Gerna, G., Reitz, M., Gallo, R., Weichold, F. (1998) Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. Blood 91, 4444-4450.
134. Sozzani, S., Ghezzi, S., Iannolo, G., Luini, W., Borsatti, A., Polentarutti, N., Sica, A., Locati, M., Mackay, C., Wells, T., Biswas, P., Vicenzi, E., Poli, G., Mantovani, A. (1998) Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J. Exp. Med. 187, 439-444.
135. DiMarzio, P., Tse, J., Landau, N. R. (1998) Chemokine receptor regulation and HIV type I tropism in monocyte-macrophages. AIDS Res. Human Rtlroviruses 14, 129-138.
136. Tuttle, D. L., Harrison, J. K., Anders, C., Sleasman, J. W., Goodenow, M. M. (1998) Expression of CCR5 increases during macrophage differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J. Virol. 72, 4962-4969.
137. Schmidtmayerova, H., Alfano, M., Nuovo, G., Bukrinsky, M. (1998) Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: Replication is restricted at a postentry level. J. Virol. 72, 4633-4642.
138. Yi, Y., Rana, S., Turner, J. D., Gaddis, N., Collman, R. G. (1998) CXCR4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of HIV-1. J. Virol. 72, 772-777.
139. Oliva, A., Kinter, A. L., Vaccarezza, M., Rubbert, A., Catanzaro, A., Moir, S., Monaco, J., Ehler, L., Mizell, S., Jackson, R., Li, Y., Rcmano, J. W., Fauci, A. S. (1998) Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of C-C-chemokines and suppress HIV-1 entry and replication in vitro. J. Clin. Invest. 102, 223-231.
140. + patients produce C-C chemokines and inhibit HIV-1 infection. J. Immunol. 161, 6433-6438.
141. Bernstein, Z. P., Porter, M. M., Gould, M., Lipman, B., Bluman, E. M., Stewart, C. C., Hewitt, R. G., Fyfe, G., Poiesz, B., Caliguiri, M. A. (1995) Prolonged administration of low-dose interleukin-2 in human immunode-ficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity. Blood 86, 3287-3294.
142. Bernstein, Z. P., Barresi, G., Gould, M., Poiesz, B., Caliguiri, M. A. (1997) A phase II study of daily subcutaneous (sq) low dose interleukin-2 (IL-2) in HIV-associated malignancy. J. Acquired Immune Deficiency Syndrome Human Retroviruses 14, 40A.
143. Maghazachi, A. A., Al-Aoukaty, A. (1998) Chemokines activate natural killer cells trhough heterotrimeric G-proteins: implications for the treatment of AIDS and cancer. FASEB J. 12, 913-924.
144. Taub, D. D., Sayers, T. J., Carter, C. R., Ortaldo, J. R. (1995) Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J. Immunol. 155, 3877-3888.
145. Bleul, C., Wu, L., Hoxie, J., Springer, T., Mackay, C. (1997) The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94, 1925-1930.
146. Granelli-Piperno, A., Delgado, E., Finkel, V., Paxton, W., Steinman, R. M. (1998) Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type I, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 72, 2733-2737.
147. Unutmaz, D., Littman, D. R. (1997) Expression pattern of HIV-1 coreceptors on T cells: Implications for viral transmission and lymphocyte homing. Proc. Natl. Acad. Sci. USA 94, 1615-1618.
148. Riley, J., Levine, B., Craighead, N., Francomano, T., Kim, D., Carroll, R., June, C. (1998) Naive and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implications for transmission and pathogenesis. J. Virol. 72, 8273-8280.
149. Spina, C., Prince, H., Richman, D. (1997) Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro. J. Clin. Invest. 99, 1774-1785.
150. Roederer, M., Raju, P., Mitra, D., Herzenberg, L., Herzenberg, L. (1997) HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28. J. Clin. Invest. 99, 1555-1564.
151. Sallusto, F., Lenig, D., Mackay, C., Lanzavecchia, A. (1998) Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187, 875-883.
152. Sallusto, F., Lanzavecchia, A., Mackay, C. R. (1998) Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol. Today 19, 568-574.
153. + T-helper 1 (Th1)- and Th2-type conditions. J. Virol. 73, 316-324.
154. Jourdan, P., Abbal, C., Nora, N., Hori, T, Uchiyama, T., Vendrell, J., Bousquet, J., Taylor, N., Pene, J., Yssel, H. (1998) IL-4 induces functional cell-surface expression of CXCR4 on human T cells. J. Immunol. 160, 4153-1157.
155. + T lymphocytes and enhance HIV-1 replication. J. Leukoc. Biol. 64, 643-649.
156. Galli, G., Annunziato, F., Mavilia, C., Romagnani, P., Cosmi, L., Manetti, R., Pupili, C., Maggoi, E., Romagnani, S. (1998) Enhanced HIV expression during Th2-oriented responses explained by the opposite regulatory effect of IL-4 and IFN-γ on fusin/CXCR4. Eur. J. Immunol. 28, 3280-3290.
157. Lee, B., Bailer, R. T., Rucker, J., Tsang, M., Doms, R. W., Montaner, L. J. (1998) Biological consequences of chemokine receptor polarization on Th1 and Th2 cells from individuals wild-type for CCR5 or homozygous for the delta-32 CCR5 allele. Blood 92, 21a.
158. Valentin, A., Lu, W., Rosati, M., Schneider, R., Albert, J., Karlsson, A., Pavlakis, G. (1998) Dual effects of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression. Proc. Natl. Acad. Sci. USA 95, 8886-8891.
159. Shearer, G. M. (1998) HIV-induced immunopathogenesis. Immunity 9, 587-593.
160. Riley, J., Carroll, R., Levine, B., Bernstein, W., St. Louis, D., Weislow, O., June, C. (1997) Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. J. Immunol. 158, 5545-5553.
161. + T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 272, 1939-1943.
162. Loetscher, P., Seitz, M., Baggiolini, M., Moser, B. (1996) Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184, 569-577.
163. + T cells. Science 276, 273-276.
164. Moriuchi, H., Moriuchi, M., Fauci, A. (1997) Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. J. Immunol. 159, 5441-5449.
165. Kornbluth, R., Kee, K., Richman, D. (1998) CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive beta-chemokines. Proc. Natl. Acad. Sci. USA 95, 5205-5210.
166. Caux, C., Masssacrier, C., Vandervliet, B., Dubois, B., VanKooten, C., Dutrand, I., Banchereau, J. (1994) Activation of human dendritic cells through CD40 cross-linking. J. Leukoc. Biol. 180, 1263-1272.
167. + cells. J. Immunol. 161, 6223-6227.
168. + T cells and monocytes from cord and adult blood. AIDS Research Human Retroviruses 14, 607-617.
169. Wu, L., Paxton, W. A., Kassam, N., Ruffing, N., Rottman, J. B., Sullivan, N., Choe, H., Sodroski, J., Newman, W., Koup, R. A., Mackay, C. R. (1997) CCR5 levels and expression pattern correlates with infectability by macrophage-tropir HIV-1 in vitro. J. Exp. Med. 185, 1681-1691.
170. + lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection. J. Virol. 72, 9054-9060.
171. + T lymphocytes by HIV-1. J. Exp. Med. 187, 1139-1144.
172. + T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. Proc. Natl. Acad. Sci. USA 95, 3111-3116.
173. Tomhave, E. D., Richardson, R. M., Didsbury, J. R., Menard, L., Synderman, R., Ali, H. (1994) Cross-desensitization of receptors for peptide chemoattractants. J. Immunol. 153, 3267-3275.
174. Blackwood, R. A., Hartiala, K. T., Kwoh, E. E., Transue, A. T., Bower, R. C. (1996) Unidirectional heterologous receptor desensitization between both the fMLP and C5a receptor and the IL-8 receptor. J. Leukoc. Biol. 60, 88-93.
175. Oravecz, T., Pall, M., Roderiquez, G., Gorrell, M. D., Ditto, M., Nguyen, N. Y., Boykins, R., Unsworth, E., Norcross, M. A. (1997) Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186, 1865-1872.
176. Ohtsuki, T., Hosono, O., Kobayashi, H., Munakata, Y., Souta. A., Shioda, T., Morimoto, C. (1998) Negative regulation of the anti-human immunodeficiency virus and chemotactic activity of human stromal cell-derived factor 1 alpha by CD26/dipeptidyl peptidase IV. FEBS Lett. 431, 236-240.
177. Proost, P., Struyf, S., Schols, D., Durinx, C., Wuyts, A., Lenaerts, J. P., Clercq, E. D., Meester, I. D., Damme, J. V. (1998) Processing by CD26/dipeptidyl peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell derived factor-1 alpha. FEBS Lett. 432, 73-76.
178. Shioda, T., Kato, H., Ohnishi, Y., Tashiro, K., Ikegawa, M., Nakayama, E. E., Hu, H., Kato, A., Sakai, Y., Liu, H., Honjo, T., Nomoto, A., Iwamoto, A., Morimoto, C., Nagai, Y. (1998) Anti-HIV-1 and chemotactic activities of stromal cell-derived factor 1 alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated clevage. Proc. Natl. Acad. Sci. USA 95, 6331-6336.
179. Westendorp, M. O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., Debatin, K. M., Krammer, P. H. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375, 497-500.
180. Albini, A., Ferrini, S., Benelli, R., Sforzini, S., Giunciuglio, D., Aluigi, M. G., Proudfoot, A. E. I., Alouani, S., Wells, T. N. C., Mariani, G., Rabin, R. L., Farber, J. M., Noonan, D. M. (1998) HIV tat protein mimicry of chemokines. Proc. Natl. Acad. Sci. USA 95, 13153-13158.
181. Zagury, D., Abderrahim, L., Chams, V., Fal, L. S., Bernard, J., Zagury, J.-F., Bizzini, B., Gringeri, A., Santagostino, E., Rappaport, J., Feldman, M., Burny, A., Gallo, R. C. (1998) Interferon α and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc. Natl. Acad. Sci. USA 95, 3851-3856.
182. Huang, L., Bosch, I., Hofmann, W., Sodroski, J., Pardee, A. B. (1998) Tat protein induces human immunodeficiency virus type I (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J. Virol. 72, 8952-8960.
183. Ho, D. D. (1998) Toward HIV eradication or remission: the tasks ahead. Science 280, 1866-1867.
184. Cohen, J. (1998) Exploring how to get at - and eradicate - hidden HIV. Science 279, 1854-1855.
185. Chun, T. W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A., Baseler, M., Lloyd, A. L., Novak, M. A., Fauci, A. S. (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94, 13193-13197.
186. Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., Gallant, J., Markowitz, M., Ho, D. D., Richman, D. D., Siliciano, R. F. (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295-1300.
187. Murakami, T., Nakajima, T., Koyanagi, Y., Tachibana, K., Fujii, N., Tamamura, H., Yoshida, N., Waki, M., Matsumoto, A., Yoshie, O., Kishimoto, T., Yamamoto, N., Nagasawa, T. (1997) A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J. Exp. Med. 186, 1389-1393.
188. Simmons, G., Clapham, P. R., Picard, L., Offord, R. E., Rosenkilde, M. M., Schwartz, T. W., Buser, R., Wells, T. N. C., Proudfoot, A. E. I. (1997) Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science 276, 276-279.
189. Donzella, G. A., Schols, D., Lin, S. W., Esté, J. A., Nagashima, K. A., Maddon, P. J., Allaway, G. P., Sakmar, T. P., Henson. G., De Clerq, E., Moore, J. P. (1998) AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nature Med. 4, 72-77.
190. Doranz, B. J., Grovit-Ferbas, K., Sharron, M. P., Mao, S.-H., Goetz, M. B., Daar, E. S., Doms, R. W., O'Brien, W. A. (1997) A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J. Exp. Med. 186, 1395-1400.
191. + cell suppression of HIV replication. J. Immunol. 159, 5123-5131.
192. + T-cell-mediated suppression of HIV-1 long terminal repeat-driven gene expression is not modulated by the CC chemokines RANTES, macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta. AIDS 11, 575-580.
193. + T-cell derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages. Proc. Natl. Acad. Sci. USA 93, 15341-15345.